Elon Musk's Neuralink said on Monday that it had raised $650 million in its latest funding round as its brain implant device ...

ClearSight, a leading provider of advanced vision correction solutions, is now offering the PanOptix® Trifocal Intraocular ...

In the evolving field of neurodegenerative medicine, the challenge is not merely discovering new treatments but ensuri ...

The company has received FDA Breakthrough Device Designation for its Blindsight vision restoration system and a speech ...

Neuralink just closed a hefty $650 million Series E round, pushing its valuation past the $9 billion mark. Backed by big names like ARK Invest, Founders Fund, Sequoia Capital, QIA and Valor Equity ...

Detailed data will be presented at a future medical meeting and submitted for regulatory review later this year.

Neuralink closed its funding round with participation from key investors including ARK Invest, DFJ Growth, Founders Fund, G42 ...

In today’s environment, aligning the Target Product Profile with the appropriate Value Evidence Archetype is not just good ...

Elon Musk's Neuralink said on Monday that it had raised $650 million in its latest funding round as its brain implant device ...

Elon Musk’s brain-computer interface company, Neuralink, has secured $650 million in a fresh funding round as it moves ahead with ...

A 48-year-old from Suffolk County is one of over 30 people suing Ozempic's manufacturer for partial loss of vision.